Long-term ALS survival benefit with CNM-Au8 seen in trial analyses
Por um escritor misterioso
Descrição
/wp-content/uploads/2023/09/AI-Medic
Cells, Free Full-Text
Long-term ALS survival benefit with CNM-Au8 seen in trial analyses, HEALEY ALS trial now tested therapy for up to 2.5 years in patients
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation - Advantx Pharmaceuticals Inc.
Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression
Clene Nanomedicine (@CleneNano) / X
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development - Paganoni - 2022 - Annals of Neurology - Wiley Online Library
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development - Paganoni - 2022 - Annals of Neurology - Wiley Online Library
cdn.sanity.io/images/0vv8moc6/neurolive/6a4093ab3e
Innovating Clinical Trials for Amyotrophic Lateral Sclerosis
A Mechanism Underpinning the Bioenergetic Metabolism‐Regulating Function of Gold Nanocatalysts - Wang - Small - Wiley Online Library
de
por adulto (o preço varia de acordo com o tamanho do grupo)